Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gianni

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
The New Microbiologica|May 29, 2004
An imported case of adult T cell leukemia in a HTLV-I-infected patient in ItalyM C Re, L Gianni, M Sassi, et al.
Anti-Cancer Drugs|July 27, 2000
Inter-relationships of paclitaxel disposition, infusion duration and cremophor EL kinetics in cancer patientsL van Zuylen, L Gianni, J Verweij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2000
Impact of nodal status on indication for adjuvant treatment in clinically node negative breast cancer. Istituto Nazionale per lo Studio e las Cura dei TumoriM Greco, M Gennaro, P Valagussa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1991
Activity and toxicity of 4'-iodo-4'-deoxydoxorubicin in patients with advanced breast cancerL Gianni, G Capri, M Greco, et al.
Journal of the National Cancer Institute|March 21, 1990
Pharmacology and clinical toxicity of 4'-iodo-4'-deoxydoxorubicin: an example of successful application of pharmacokinetics to dose escalation in phase I trialsL Gianni, L Viganò, A Surbone, et al.
Cancer Research|February 1, 1983
Pharmacokinetics of the hypoxic radiosensitizers misonidazole and demethylmisonidazole after intraperitoneal administration in humansL Gianni, J F Jenkins, R F Greene, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humansL Gianni, C M Kearns, A Giani, et al.
American Journal of Clinical Oncology|June 1, 1990
Cisplatin and cyclophosphamide in advanced ovarian carcinoma: activity and toxicity of an ambulatory regimenM Zambetti, L Gianni, F Di Re, et al.
European Journal of Nuclear Medicine|July 15, 1998
Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosisP N Hawkins, C Aprile, G Capri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2007
Phase I clinical study of the novel epothilone B analogue BMS-310705 given on a weekly scheduleC Sessa, A Perotti, A Lladò, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
The New Microbiologica|May 29, 2004
An imported case of adult T cell leukemia in a HTLV-I-infected patient in ItalyM C Re, L Gianni, M Sassi, et al.
Anti-Cancer Drugs|July 27, 2000
Inter-relationships of paclitaxel disposition, infusion duration and cremophor EL kinetics in cancer patientsL van Zuylen, L Gianni, J Verweij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2000
Impact of nodal status on indication for adjuvant treatment in clinically node negative breast cancer. Istituto Nazionale per lo Studio e las Cura dei TumoriM Greco, M Gennaro, P Valagussa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1991
Activity and toxicity of 4'-iodo-4'-deoxydoxorubicin in patients with advanced breast cancerL Gianni, G Capri, M Greco, et al.
Journal of the National Cancer Institute|March 21, 1990
Pharmacology and clinical toxicity of 4'-iodo-4'-deoxydoxorubicin: an example of successful application of pharmacokinetics to dose escalation in phase I trialsL Gianni, L Viganò, A Surbone, et al.
Cancer Research|February 1, 1983
Pharmacokinetics of the hypoxic radiosensitizers misonidazole and demethylmisonidazole after intraperitoneal administration in humansL Gianni, J F Jenkins, R F Greene, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humansL Gianni, C M Kearns, A Giani, et al.
American Journal of Clinical Oncology|June 1, 1990
Cisplatin and cyclophosphamide in advanced ovarian carcinoma: activity and toxicity of an ambulatory regimenM Zambetti, L Gianni, F Di Re, et al.
European Journal of Nuclear Medicine|July 15, 1998
Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosisP N Hawkins, C Aprile, G Capri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2007
Phase I clinical study of the novel epothilone B analogue BMS-310705 given on a weekly scheduleC Sessa, A Perotti, A Lladò, et al.
Pageof 11